Crohn's and Colitis Canada to Launch National Campaign in Support of IBD Precision Medicine Research Program

TORONTO, Nov. 5, 2026 /CNW/ -- The future of inflammatory bowel disease (IBD) research and care in Canada will launch with a national precision medicine initiative on Friday, November 6^th in Toronto. The CN Tower will illuminate red in recognition of Crohn's and Colitis Awareness Month, with landmarks in communities across Canada also lighting up throughout November to raise visibility for Crohn's disease and ulcerative colitis and Canadians living with these conditions.

Interview & Photo Opportunities - The launch will bring together researchers, clinicians, people with lived experience, donors and community leaders to spotlight the potential of precision medicine to move IBD care towards a more personalized approach with predicting, detecting, treating and managing diseases. Advance and on-site interviews can be coordinated with organizational, clinical/research, and lived-experience spokespeople.

• WHO: Leading Canadian IBD researchers and clinicians, people living with IBD and patient ambassadors, Crohn's and Colitis Canada leadership, government representatives (TBC), donors, partners, and other members of the IBD research community participating in Crohn's and Colitis Canada's annual Meeting of the Minds.
• WHAT: National launch of Crohn's and Colitis Canada's IBD Precision Medicine Research Program and public awareness campaign.
• WHERE: The Westin Harbour Castle, 1 Harbour Square, Toronto, Ontario. Followed by a reception at the CN Tower Main Observation Level.
• WHEN: Friday, November 6, 2026. Formal program begins at 5:00 p.m. and runs approximately 30 minutes. [Media check-in 4:00 PM onwards]
• WHY IT MATTERS: More than 322,000 people in Canada currently live with Crohn's or colitis, and the number is projected to reach 470,000 by 2035. The new research effort is designed to accelerate precision medicine for IBD -- research that could help reduce trial and error and move care toward more predictive, personalized approaches.

SOURCE Crohn's and Colitis Canada

Media RSVP/interview requests: Daud Arif, Specialist, Impact Communications and Executive Operations, Crohn's and Colitis Canada, [email protected], 647-914-9883; Ankita Maneck, Account Executive, ChangeMakers, [email protected], 437-986-5246; Grace May, Account Executive, ChangeMakers, [email protected], 647-549-9983